#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ewing's sarcoma recurrent Nephroblastoma Eosinophilic oesophagitis Chronic cutaneous lupus erythematosus Mantle cell lymphoma stage IV Congenital nephrogenic diabetes insipidus Mantle cell lymphoma stage II Cardiomyopathy Tuberous sclerosis complex Haemophilia A with anti factor VIII Deafness bilateral Leiomyosarcoma metastatic Adrenocortical carcinoma Diffuse large B-cell lymphoma Non-Hodgkin's lymphoma unspecified histology indolent More trials…

    Learn about Rare Diseases

    Noonan syndrome Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Marfan’s syndrome – Life with Disease Undifferentiated sarcoma – Treatment Prolymphocytic leukaemia – Trials in Disease Mantle cell lymphoma stage III – Trials in Disease Castleman’s disease – Diagnostics Ewing’s sarcoma recurrent – Basic Information Hyperoxaluria Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Falbikitug 177LU-FAP-2286 Nandrolone Decanoate Depemokimab Povidone Vb10.16 NALDEMEDINE Hydrocortisone Acetate Letetresgene Autoleucel Lutropin Alfa L-Tryptophan Gs-4182 Adrenaline Acid Tartrate Bp Idelalisib VERCIRNON Iomeprol Ramipril Aclidinium Bromide NORELGESTROMIN ARI0008 More therapies…

    Learn about Your Condition

    Hereditary ataxia Cerebral haemorrhage Meniscus injury Juvenile psoriatic arthritis Adenocarcinoma pancreas Prostate cancer recurrent Ejection fraction normal Ocular lymphoma Haemorrhoids Transplantation complication Aplasia pure red cell Small cell lung cancer Oxygen saturation Tonsillitis Infantile apnoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Metabolism

  • Study on the Safety and Effectiveness of Diamyd and Colecalciferol for Adolescents and Adults with Recently Diagnosed Type 1 Diabetes

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Glutamate Decarboxylase 2, Human, Recombinant
    • Colecalciferol
    Czechia Estonia Germany Hungary The Netherlands Poland +2

  • Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

    Not recruiting

    2 1
    Investigated Drugs:
    • Azd4831
    Denmark Italy Norway Portugal Spain Sweden

  • Study on Metreleptin for Patients with Partial Lipodystrophy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Metreleptin
    Belgium The Netherlands Poland Spain

  • Study on Metreleptin for Children Under 6 with Generalized Lipodystrophy and Related Diabetes or High Triglycerides

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Congenital generalised lipodystrophy
    Investigated Drugs:
    • Metreleptin
    Belgium France Germany Italy

  • Study on the Effectiveness and Safety of CR9114 for Preventing Influenza in Healthy Adults

    Not recruiting

    2 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • WILD-TYPE A INFLUENZA VIRUS A/BELGIUM/4217/2015 (H3N2)
    Belgium

  • Study of Tirzepatide and Placebo for People with Overweight or Obesity and Chronic Kidney Disease, with or without Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Chronic kidney disease
    • Obesity
    Investigated Drugs:
    • Iohexol
    • Tirzepatide
    Austria Denmark The Netherlands
Previous Page
1 … 5 6 7

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!